Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -6.63x is 16% below its 2-year average of -5.71x, around the middle of its 2-year range (-9.27x–-2.19x).
9.50% above its 12-month average of -7.33x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -9.27x.
INTEREST COVERAGE RATIO
-6.63x
INTEREST COVERAGE RATIO AVG TTM
-7.33x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+9.50%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-4.00%
vs the sector median at left
Palvella Therapeutics, Inc.
Market Cap
$1.87B
Interest Coverage Ratio
-6.63x
TTM Avg
-7.33x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.89B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.89B
Interest Coverage Ratio
-0.40x
TTM Avg
732.40x
3Y Avg
732.40x
5Y Avg
732.40x
Market Cap
$1.84B
Interest Coverage Ratio
N/A
TTM Avg
1.77x
3Y Avg
2.62x
5Y Avg
35.29x
Market Cap
$1.90B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.91B
Interest Coverage Ratio
-1.54x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.83B
Interest Coverage Ratio
1.57x
TTM Avg
2.14x
3Y Avg
5.67x
5Y Avg
7.21x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Palvella Therapeutics, Inc. (PVLA) | $1.87B | -6.63x | -7.33x | N/A | N/A |
| Immunome, Inc. (IMNM)vs › | $1.88B | N/A | N/A | N/A | N/A |
| Zymeworks Inc. (ZYME)vs › | $1.89B | N/A | N/A | N/A | N/A |
| Trevi Therapeutics, Inc. (TRVI)vs › | $1.89B | N/A | N/A | N/A | N/A |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | -0.40x | 732.40x | 732.40x | 732.40x |
| Azenta, Inc. (AZTA)vs › | $1.84B | N/A | 1.77x | 2.62x | 35.29x |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.90B | N/A | N/A | N/A | N/A |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.91B | -1.54x | N/A | N/A | N/A |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 1.57x | 2.14x | 5.67x | 7.21x |
| Novavax, Inc. (NVAX)vs › | $1.82B | 24.98x | 24.98x | 24.98x | 24.98x |
Interest Coverage
-6.6x
Debt/Equity
0.00
Current Ratio
21.18
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -9.27x |
| 2026-03-31 | -7.29x |
| 2025-12-31 | -6.50x |
| 2025-09-30 | -6.74x |
| 2025-06-30 | -6.83x |
| 2025-03-31 | -6.48x |
| 2024-12-31 | -3.35x |
| 2024-06-30 | -2.75x |
| 2024-03-31 | -2.19x |
